Work

Supplementary Figure S5 from Immunologic Profiling of Immune-Related Cutaneous Adverse Events with Checkpoint Inhibitors Reveals Polarized Actionable Pathways

Year: 2024
Type: supplementary-materials
Abstract: Supplementary Figure S5. Treatment responses of patients with immune-related cutaneous adverse events (ircAEs; Cohort 1).
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
OpenAlex ID: W4400215270
Cites:
Cited by:
Related to: 10